Biblio Discovery — Demo Discovery Service

5 results for "Andrea Beharry"

Showing 1–5 · 0.68 seconds · RSS

  1. Journal Article Full text

    ATM Immunohistochemistry as a Tool to Identify and Classify Somatic ATM Variants in Prostate Cancer

    Roger Ferreira; Kassandra R. Bisson; Andrea Beharry et al.

    Journal of Molecular Pathology, Vol. 7 No. 2 · 2026 · English · DOAJ Scopus

    Background/Objectives: Ataxia telangiectasia-mutated kinase is encoded by the ATM gene. This gene is altered in many cancer types; however, it is most relevant for eligibility of poly-ADP-ribose polymerase inhibitor (PARPi) therapy in metastatic castrate-resistant prostate cancer in Canada…

  2. Journal Article Full text

    Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery

    Kassandra R. Bisson; Jennifer R. Won; Andrea Beharry et al.

    Journal of Molecular Pathology, Vol. 5 No. 1 · 2024 · English · DOAJ Scopus

    Biomarkers are fundamental to modern oncology practice, forming a close link to pathology practice. Pathology results must be accurate, timely, comprehensive, and comprehendible. External proficiency testing is a key tool in maintaining biomarker quality. Here, we demonstrate the feasibility and…

  3. Journal Article Full text

    Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care

    Brandon S. Sheffield; Andrea Beharry; Joanne Diep et al.

    Current Oncology, Vol. 29 No. 3 · 2022 · English · DOAJ Scopus

    Purpose: Biomarker data are critical to the delivery of precision cancer care. The average turnaround of next-generation sequencing (NGS) reports is over 2 weeks, and in-house availability is typically limited to academic centers. Lengthy turnaround times for biomarkers can adversely affect…

  4. Journal Article

    Novel Approach to Proficiency Testing Reveals Significant Variations in Biomarker Practice Leading to Critical Differences in Lung Cancer Management

    Kassandra R. Bisson, MHSc; Andrea Beharry, MLT; Normand Blais, MD et al.

    JTO Clinical and Research Reports, Vol. 6 No. 7 · 2025 · English · DOAJ Scopus

    Introduction: Timely access to quality biomarker testing in NSCLC is critical to patient outcomes. The Canadian Pathology Quality Assurance provides external quality assurance (EQA) to laboratories in Canada. The Canadian Pathology Quality Assurance has recently developed a novel approach to…